Navigation Links
DePuy Hip Settlement News: Number of Federal Pinnacle Cases Now Exceeds 5,000, Rottenstein Law Group LLP Reports

(PRWEB) December 06, 2013

The number of DePuy Pinnacle hip lawsuits in federal court increased by 100 in November, putting the total number of pending lawsuits at about 5,300, according to recently released court documents. The Rottenstein Law Group LLP, which represents clients in DePuy hip lawsuits and maintains the DePuy lawsuits informational website at, discusses the Pinnacle lawsuits and their relation to DePuy settlements.

There are currently 5,293 Pinnacle lawsuits pending in Texas in a consolidation of federal court cases for pretrial efficiency, according to court documents (In re: DePuy Orthopaedics, Inc., Pinnacle Hip Implant Products Liability Litigation; MDL-22244, U.S. District Court for the Northern District of Texas).

Pinnacle lawsuits are not included in the recently announced multibillion dollar DePuy settlement, according a Nov. 27 Bloomberg report.* However, like the ASR hip implant that is included in the settlement, the Pinnacle has the potential to cause serious alleged side effects such as device failure and metal poisoning, according to court documents. Unlike the ASR, which was recalled in 2010, the Pinnacle hip implant is still on the market.

“An increasing number of lawsuits is not surprising,” said Rochelle Rottenstein, principal of the Rottenstein Law Group LLP. “We are hearing more and more each day from people who seek legal counsel because of the alleged side effects of the Pinnacle.”

Johnson & Johnson and its subsidiary DePuy Orthopaedics agreed to the multibillion dollar DePuy ASR settlement last month as a way to resolve a majority of the ASR lawsuits pending, according to a Nov. 20 New York Times report.**

The Rottenstein Law Group LLP encourages those who believe they have suffered from the Pinnacle’s alleged side effects to visit its FAQ page to learn more about DePuy Pinnacle hip lawsuits and side effects, and how to contact an attorney for a free consultation.



The Rottenstein Law Group LLP is a New York-based firm that represents clients nationwide in mass tort actions. The firm was founded by Rochelle Rottenstein, who has more than two decades of experience as a lawyer, to represent clients hurt by defective medical devices and medications. (Attorney advertising. Prior results do not guarantee a similar outcome.)

The Rottenstein Law Group LLP
Rochelle Rottenstein, Esq.
321 W. 44th Street
# 804
New York NY 10036
(212) 933-9500 (office phone)
(212) 933-9980 (facsimile)
rochelle (at) rotlaw (dot) com

Read the full story at

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. DePuy Pinnacle Hip Lawsuit News: Bernstein Liebhard LLP Notes Order Delaying Consideration of Remand Motions in Federal Pinnacle Hip Litigation
2. DePuy Pinnacle Lawsuit Claims Mount, as Bernstein Liebhard LLP Notes Nearly 6,000 Filings in Federal Pinnacle Hip Litigation
3. DePuy ASR Lawsuit Settlement Update: Rottenstein Law Group LLP Comments on Report of Proposed Additional Compensation
4. DePuy Settlement Update: DePuy Pinnacle Lawsuits Progress in Federal Court, Rottenstein Law Group LLP Reports
5. DePuy ASR Lawsuit Settlement Update: Retired Judge Selected As Claims Administrator, Rottenstein Law Group LLP Reports
6. DePuy ASR™ MDL Lawsuit Update: Settlement Reached in the DePuy ASR™ Hip Implant Multidistrict Litigation (MDL 2197)
7. Chicago Personal Injury Firm of Salvi, Schostok and Pritchard P.C. Calls Attention to Proposed $2.5 Billion DePuy Hip Implant Settlement
8. DePuy ASR Lawsuit Settlement Proposal Moves Forward, as Bernstein Liebhard LLP Notes Issuance of New Order in Federal DePuy ASR Recall Litigation
9. DePuy ASR Settlement News: Bernstein Liebhard LLP Notes Appointment of Special Masters, Claims Administrator to Oversee Proposed DePuy ASR Lawsuit Settlement
10. DePuy ASR Lawsuit Settlement News: Johnson & Johnson Deal Still Leaves Opportunity to File Lawsuits, Notes Rottenstein Law Group LLP
11. DePuy Pinnacle Lawsuit News: Bernstein Liebhard LLP Notes Scheduling of Remand Hearings for Federal Pinnacle Hip Lawsuits
Post Your Comments:
(Date:6/26/2016)... , ... June 26, 2016 , ... ... once they have been diagnosed with endometriosis. These women need a treatment plan ... require a comprehensive approach that can help for preservation of fertility and ultimately ...
(Date:6/25/2016)... ... June 25, 2016 , ... First Choice Emergency Room , the ... Ogunleye, as the Medical Director of its new Mesquite-Samuell Farm facility. , “We ... new Mesquite location,” said Dr. James M. Muzzarelli, Executive Medical Director of First Choice ...
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article published June ... with. The article goes on to state that individuals are now more comfortable seeking ... common operations such as calf and cheek reduction. The Los Angeles area medical group, ...
(Date:6/24/2016)... MIAMI, Fla. (PRWEB) , ... June 24, 2016 , ... ... Florida Trend magazine’s 2016 Legal Elite. The attorneys chosen by their peers for this ... of Florida. , Seven Greenberg Traurig Shareholders received special honors as members of this ...
(Date:6/24/2016)... ... 2016 , ... EB Medicine presented its first-ever “Issue of ... in Ponte Vedra Beach, FL. The awards honor the outstanding work of leading ... and Pediatric Emergency Medicine Practice. , “With this award, we recognize the efforts ...
Breaking Medicine News(10 mins):
(Date:6/24/2016)... Belgium , June 24, 2016 /PRNewswire/ ... announced the appointment of Dr. Edward Futcher ... a Non-Executive Director, effective June 23, 2016.Dr. Futcher ... and Nominations and Governance Committees.  As a non-executive ... provide independent expertise and strategic counsel to VolitionRx ...
(Date:6/23/2016)... , June 23, 2016 ... "Pharmaceutical Excipients Market by Type (Organic Chemical (Sugar, ... Formulation (Oral, Topical, Coating, Parenteral) - Global Forecast to ... The global pharmaceutical excipients market ... at a CAGR of 6.1% in the forecast period ...
(Date:6/23/2016)... DUBLIN , June 23, 2016 ... "Key Pharma News Issue 52" report to their offering. ... need in influenza treatment creates a favourable commercial environment for ... and growing patient base that will serve to drive considerable ... flu vaccine would serve to cap sales considerably, but development ...
Breaking Medicine Technology: